findmyKOL

Amanda Renaghan, MD

Basic profile

University of Virginia Health System

ORCIDNPI
RegionCharlottesville, VA · SoutheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Amanda Renaghan is a Nephrology physician affiliated with University of Virginia Health System. OpenAlex indexes 30 publications with 3,530 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
30publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,530citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

199 Spotnap Rd Ste 1
Charlottesville, VA 229118827

Telephone

434-971-8888

Provider last certified this registry record 11 Aug 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54%
    Angiotensin receptor blocker (ARB)20.2%
    Losartan Potassium100%
    Part D17 patients
    Calcium channel blocker13.6%
    Amlodipine Besylate100%
    Part D11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    40.1%
    Vitamin D3 Analog19.5%
    Calcitriol100%
    Part D14 patients
    SGLT2 inhibitor11.8%
    Jardiance100%
    Part D<11 patients

    + 2 more classes in this area

  • Genitourinary & hormones

    5.9%
    alpha-Adrenergic Blocker5.9%
    Tamsulosin Hcl100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”